• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Analysis of dysmenorrhea-related factors in adenomyosis and development of a risk prediction model.子宫腺肌病痛经相关因素分析及风险预测模型的建立
Arch Gynecol Obstet. 2025 Apr;311(4):1081-1089. doi: 10.1007/s00404-025-07967-y. Epub 2025 Mar 17.
2
Development and validation of a nomogram to predict depression in older adults with heart disease: a national survey in China.预测老年心脏病患者抑郁的列线图的开发与验证:一项中国全国性调查
Front Public Health. 2024 Dec 11;12:1469980. doi: 10.3389/fpubh.2024.1469980. eCollection 2024.
3
Development and validation of a nomogram model to predict the risk of strangulated intestinal obstruction.预测绞窄性肠梗阻风险的列线图模型的开发与验证
Sci Rep. 2024 Dec 28;14(1):31049. doi: 10.1038/s41598-024-82131-1.
4
[Analysis of the relationship between MRI imaging characteristics and clinical symptoms and therapeutic efficacy in adenomyosis patients].子宫腺肌病患者MRI成像特征与临床症状及治疗效果的关系分析
Zhonghua Fu Chan Ke Za Zhi. 2023 May 25;58(5):343-350. doi: 10.3760/cma.j.cn112141-20221130-00727.
5
Clinical profiles of 710 premenopausal women with adenomyosis who underwent hysterectomy.710例接受子宫切除术的子宫腺肌病绝经前女性的临床资料。
J Obstet Gynaecol Res. 2014 Feb;40(2):485-94. doi: 10.1111/jog.12211. Epub 2013 Oct 22.
6
[Analysis of related factors on effects of uterine artery embolization in the treatment of dysmenorrhea of adenomyosis and the construction and validation of prediction model].子宫动脉栓塞术治疗子宫腺肌病痛经效果的相关因素分析及预测模型的构建与验证
Zhonghua Fu Chan Ke Za Zhi. 2016 Sep 25;51(9):650-656. doi: 10.3760/cma.j.issn.0529-567X.2016.09.003.
7
[Establishment and evaluation of a nomogram model for predicting the risk of sepsis in diabetic foot patients].[糖尿病足患者脓毒症风险预测列线图模型的建立与评价]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Jul;36(7):693-698. doi: 10.3760/cma.j.cn121430-20240327-00294.
8
A novel nomogram based on the patient's clinical data and CT signs to predict poor outcomes in AIS patients.一种基于患者临床数据和CT征象的新型列线图,用于预测急性缺血性卒中(AIS)患者的不良预后。
PeerJ. 2025 Jan 6;13:e18662. doi: 10.7717/peerj.18662. eCollection 2025.
9
Transvaginal sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis: association with symptoms.18至30岁未孕且无子宫内膜异位症的女性弥漫性子宫腺肌病的经阴道超声特征:与症状的关联
Ultrasound Obstet Gynecol. 2015 Dec;46(6):730-6. doi: 10.1002/uog.14834.
10
Analysis of related factors influencing postoperative recurrence of adenomyosis treated with HIFU.高强度聚焦超声治疗子宫腺肌病术后复发相关因素分析
Arch Gynecol Obstet. 2024 May;309(5):1765-1773. doi: 10.1007/s00404-023-07340-x. Epub 2024 Feb 12.

引用本文的文献

1
Spatial, temporal and demographic distribution characteristics of adenomyosis symptom clusters from the perspective of traditional Chinese medicine: a multicenter cross-sectional study in China from 2020 to 2022.从中医角度看子宫腺肌病症状群的空间、时间和人口学分布特征:2020年至2022年中国多中心横断面研究
Front Endocrinol (Lausanne). 2025 Aug 7;16:1605310. doi: 10.3389/fendo.2025.1605310. eCollection 2025.

本文引用的文献

1
Role of ultrasonography in the evaluation of disease severity and treatment efficacy in adenomyosis.超声检查在子宫腺肌病严重程度评估及疗效评价中的作用。
Arch Gynecol Obstet. 2024 Feb;309(2):363-371. doi: 10.1007/s00404-023-07034-4. Epub 2023 Apr 28.
2
Modern view on the diagnostics and treatment of adenomyosis.现代观点下的子宫腺肌病的诊断与治疗。
Arch Gynecol Obstet. 2023 Jul;308(1):171-181. doi: 10.1007/s00404-023-06982-1. Epub 2023 Apr 15.
3
The genetic basis of endometriosis and comorbidity with other pain and inflammatory conditions.子宫内膜异位症及其与其他疼痛和炎症性疾病并存的遗传基础。
Nat Genet. 2023 Mar;55(3):423-436. doi: 10.1038/s41588-023-01323-z. Epub 2023 Mar 13.
4
Factors Associated with the Prevalence and Severity of Menstrual-Related Symptoms: A Systematic Review and Meta-Analysis.与月经相关症状的流行率和严重程度相关的因素:系统评价和荟萃分析。
Int J Environ Res Public Health. 2022 Dec 29;20(1):569. doi: 10.3390/ijerph20010569.
5
Immunological changes associated with adenomyosis: a systematic review.与子宫腺肌病相关的免疫学变化:系统评价。
Hum Reprod Update. 2021 Jan 4;27(1):108-129. doi: 10.1093/humupd/dmaa038.
6
Coronavirus disease 2019 in pregnant women: a report based on 116 cases.新型冠状病毒肺炎孕妇病例报告:基于 116 例病例的报告。
Am J Obstet Gynecol. 2020 Jul;223(1):111.e1-111.e14. doi: 10.1016/j.ajog.2020.04.014. Epub 2020 Apr 23.
7
Dysmenorrhea in patients with adenomyosis: A clinical and demographic study.子宫腺肌病患者的痛经:一项临床和人口统计学研究。
J Gynecol Obstet Hum Reprod. 2021 Mar;50(3):101761. doi: 10.1016/j.jogoh.2020.101761. Epub 2020 Apr 20.
8
The Pathogenesis of Adenomyosis vis-à-vis Endometriosis.子宫腺肌病与子宫内膜异位症的发病机制
J Clin Med. 2020 Feb 10;9(2):485. doi: 10.3390/jcm9020485.
9
Adenomyosis incidence, prevalence and treatment: United States population-based study 2006-2015.腺肌病的发病率、患病率和治疗:2006-2015 年美国基于人群的研究。
Am J Obstet Gynecol. 2020 Jul;223(1):94.e1-94.e10. doi: 10.1016/j.ajog.2020.01.016. Epub 2020 Jan 15.
10
A new trick for an old dog: The application of mifepristone in the treatment of adenomyosis.老狗也有新把戏:米非司酮在子宫腺肌病治疗中的应用。
J Cell Mol Med. 2020 Jan;24(2):1724-1737. doi: 10.1111/jcmm.14866. Epub 2019 Dec 8.

子宫腺肌病痛经相关因素分析及风险预测模型的建立

Analysis of dysmenorrhea-related factors in adenomyosis and development of a risk prediction model.

作者信息

Fu Yudan, Wang Xin, Yang Xinchun, Zhao Ruihua

机构信息

Department of Gynecology, Guang 'Anmen Hospital, Chinese Academy of Chinese Medical Sciences, No. 5, North Line Ge Street, Beijing, 10053, Xicheng District, PR China.

出版信息

Arch Gynecol Obstet. 2025 Apr;311(4):1081-1089. doi: 10.1007/s00404-025-07967-y. Epub 2025 Mar 17.

DOI:10.1007/s00404-025-07967-y
PMID:40095084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11985619/
Abstract

OBJECTIVE

To explore factors related to dysmenorrhea in adenomyosis and construct a risk prediction model.

METHODS

A cross-sectional survey involving 1636 adenomyosis patients from 37 hospitals nationwide (November 2019-February 2022) was conducted. Data on demographics, disease history, menstrual and reproductive history, and treatment history was collected.Patients were categorized into dysmenorrhea and non-dysmenorrhea groups. Multivariate logistic regression analyzed factors influencing dysmenorrhea, and a risk prediction model was created using a nomogram. The model's performance was evaluated through ROC curve analysis, C-index, Hosmer-Lemeshow test, and bootstrap method The nomogram function was used to establish a nomogram model. The model was evaluated using the area under the ROC curve (AUC), C-index, Hosmer-Lemeshow goodness-of-fit test, and bootstrap method. Patients were scored based on the nomogram, and high-risk groups were delineated.

RESULTS

Dysmenorrhea was present in 61.31% (1003/1636) of the patients. Univariate analysis showed significant differences (P < 0.05) between groups in age at onset, course of disease, oligomenorrhea, menorrhagia, number of deliveries, pelvic inflammatory disease, family history of adenomyosis, exercise, and excessive menstrual fatigue. Significant factors included menorrhagia, multiple deliveries, pelvic inflammatory disease, and family history of adenomyosis as risk factors. Older age at onset, oligomenorrhea, and exercise were identified as protective factors. The model's accuracy, discrimination, and reliability were acceptable, and a risk score > 88.5 points indicated a high-risk group.

CONCLUSION

Dysmenorrhea is prevalent among adenomyosis patients. Identifying and mitigating risk factors, while leveraging protective factors, can aid in prevention and management. The developed model effectively predicts dysmenorrhea risk, facilitating early intervention and treatment.

摘要

目的

探讨子宫腺肌病痛经的相关因素并构建风险预测模型。

方法

对全国37家医院的1636例子宫腺肌病患者进行横断面调查(2019年11月至2022年2月)。收集人口统计学、疾病史、月经和生殖史以及治疗史的数据。患者被分为痛经组和非痛经组。采用多因素logistic回归分析影响痛经的因素,并使用列线图创建风险预测模型。通过ROC曲线分析、C指数、Hosmer-Lemeshow检验和自抽样法评估模型性能。使用列线图函数建立列线图模型。采用ROC曲线下面积(AUC)、C指数、Hosmer-Lemeshow拟合优度检验和自抽样法对模型进行评估。根据列线图对患者进行评分,并划定高危组。

结果

61.31%(1003/1636)的患者存在痛经。单因素分析显示,两组在发病年龄、病程、月经过少、月经过多、分娩次数、盆腔炎、子宫腺肌病家族史、运动和经期过度疲劳方面存在显著差异(P < 0.05)。显著因素包括月经过多、多次分娩、盆腔炎和子宫腺肌病家族史为危险因素。发病年龄较大、月经过少和运动被确定为保护因素。该模型的准确性、区分度和可靠性均可接受,风险评分>88.5分表示为高危组。

结论

痛经在子宫腺肌病患者中普遍存在。识别和减轻危险因素,同时利用保护因素,有助于预防和管理。所建立的模型能有效预测痛经风险,便于早期干预和治疗。